Free Trial

Virios Therapeutics (VIRI) SEC Filings & 10K Form

Virios Therapeutics logo
$4.83 -0.12 (-2.42%)
As of 07/2/2025

Recent Virios Therapeutics SEC Filings

DateFilerForm TypeView
07/01/2025
12:52 PM
De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:56 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Walsh Angela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:58 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Keefer David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:00 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Duncan Gregory Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:02 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Thomas John C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:05 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Grosswald Ralph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:07 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
1:11 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Gendreau Roger Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:01 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/24/2025
9:15 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
10:57 AM
De La Rosa Abel (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
10:59 AM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Thomas John C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
11:02 AM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Keefer David R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
11:04 AM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Whitley Richard James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
11:15 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form EFFECT
05/23/2025
4:25 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/09/2025
10:28 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
8:20 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
1:08 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form ARS
04/30/2025
7:00 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form DEF 14A
04/03/2025
8:10 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:44 PM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2025
7:19 PM
Conjoint Inc. (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/17/2025
8:11 PM
Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Sealbond Ltd (Filed by)
Form SCHEDULE 13D/A
03/17/2025
8:07 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:53 PM
Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G/A
03/17/2025
4:49 PM
Virios Therapeutics (Subject)
Dogwood Therapeutics, Inc. (Subject)
Orca Capital AG (Filed by)
Form SCHEDULE 13G
03/14/2025
10:47 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
9:32 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 424B5
03/12/2025
8:00 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
8:30 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K/A
11/21/2024
8:15 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
7:15 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:15 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
8:25 AM
Virios Therapeutics (Filer)
Dogwood Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:29 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Toh Kean Meng Melvin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:30 PM
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Yu Ying Choi Alan Abel (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2024
3:29 PM
CK Life Sciences Intl Inc (0001297567) (Reporting)
Virios Therapeutics (Issuer)
Dogwood Therapeutics, Inc. (Issuer)
Sealbond Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/15/2024
3:19 PM
Sealbond Ltd (Filed by)
Virios Therapeutics (Subject)
Virios Therapeutics, Inc. (Subject)
Form SC 13D
10/07/2024
7:06 AM
Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
Form DEFA14A
10/07/2024
7:02 AM
Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
08/09/2024
9:15 AM
Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
8:30 AM
Virios Therapeutics (Filer)
Virios Therapeutics, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VIRI) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners